Sign inJoin waitlistJoin the waitlist

NK

Nathaniel Kleytman

Credentials:

History

Residency
2026–2029
Medical School
2022–2026

Research

Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease
Molecular Genetics and Metabolism Reports · 2021 · First of 9 authors · 19 citations
Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease
Molecular Genetics and Metabolism · 2019 · 16 citations
Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center
eLife · 2023 · 11 citations

Pramod Mistry
3 papers
Andrew Lischuk
2 papers
VM
Vagishwari Murugesan
2 papers
AT
Abenezer Tedla
1 paper · 1 as a resident
Cesar Riera-Gonzalez
1 paper
DF
Daniel Farkas
1 paper
GP
Gregory Pastores
1 paper
NJ
Nithyla John
1 paper · 1 as a resident
ST
Sania Udayan Thite
1 paper · 1 as a resident
SS
Savni Satoskar
1 paper
Yuliya Afinogenova
1 paper · 1 as a resident